NHS Trust Deploys Mobile Electronic Observation Solution to Reduce Patient Mortality

Hull and East Yorkshire Hospitals NHS Trust (HEY) have agreed a five year deal with Nervecentre to deliver their e-Observations Decision Support System trust-wide. The solution, the deployment of which has been speeded up through an award from the £100m Nursing Technology Fund, will enable the trust to reduce mortality, improve patient safety and reduce harm.

The Nervecentre solution provides clinicians with the ability to record and monitor patient observations via a mobile device. Its key functionality includes sophisticated cascading escalation, with deteriorating patients' vital signs being relayed to the most appropriate clinician in order for a "recognise and rescue" plan to be put in place. In addition, specialist functions such as Hospital-at-Night, will allow escalations out of hours - ensuring patient care remains consistent 24 hours a day and helping HEY to achieve standard 243 of the Francis Report - recording of routine observations.

Steve Jessop, the trust’s chief nurse information officer explains: "We needed smarter and more efficient ways across the organisation of detecting the sick, deteriorating patient, and providing a timely and effective response to this by clinical staff. This included the ability to target messaging to services and clinicians such as critical care outreach, junior doctors and the infection control team.

"This solution will enable us to have visibility of all deteriorating patients so that we can pro-actively intervene improving the care, management and outcomes of patients 24/7, including out of hours periods, and at weekends and bank holidays, when it can be particularly difficult to escalate manually."

Key to the trust's objectives was to improve their clinical governance processes and directly respond to the targets set by government, in particular the standards laid out by the Francis Report.

Dr Mark Simpson, emergency department consultant and trust CCIO said: "The trust was seeking a system to support patient safety and outcomes, which is an integral component of our IM&T strategy. The Nervecentre solution has everything we need and more! It will enable us to create an environment which will enhance the user experience by removing the reliance on paper records."

As well as the benefits from digitising the recording of observations, the solution will also allow HEY to remove the risk and inefficiency of paper based handover meetings by ensuring that all members of a clinical team are working from a common understanding of the status of a patient.

Simpson continued: "By giving our team the appropriate tools we will be able to drive down response times, reduce the potential for untoward incidents and ensure that incomplete tasks are appropriately escalated."

Clinical engagement is expected to be high as users can personalise the information they receive, have that information be delivered to a variety of mobile devices and access it anywhere easily and securely.

"After careful consideration of all the options available to us, Nervecentre offered both substantially more benefits as well as a more cost effective solution. The investment from the Nursing Technology Fund helped us to realise our vision much quicker than initially anticipated and we are looking forward to rolling this out across the trust” Simpson concluded.

Managing director of Nervecentre, Paul Volkaerts said: "The tender process, which began in March 2013, has allowed HEY to ensure they have made the best decision to meet their on-going vision to provide safe, high quality effective care by ensuring efficient economic use of resources - particularly staff.

"Nervecentre is looking forward to entering into a relationship which focuses so heavily on improving patient outcomes. This is central to our on-going strategy of improving patient safety and supports the work we are doing with other trusts across the UK."

In February 2014, Hull and East Yorkshire Hospitals NHS Trust was awarded £950,000 from the Nurse Technology Fund to support the roll out of an Electronic Clinical Observation System (e-COBS).

About Hull and East Yorkshire Hospitals NHS Trust
The trust was established in October 1999 following the merger of the Royal Hull Hospitals NHS Trust and East Yorkshire Hospitals NHS Trust.

They operate from two main hospital sites, namely Hull Royal Infirmary and Castle Hill Hospital in Cottingham, plus have a number of additional services based across other local estate and in the community.

Employing around 8,000 staff, they welcome around one million patients through their doors every year. They are an aspiring NHS Foundation Trust and a recognised Major Trauma Centre for the region.

About Nervecentre
Nervecentre is a healthcare focused consultancy and software development organisation founded in 2010 which is committed to enabling the NHS to improve productivity and quality through innovative, mobile collaboration technology.

Nervecentre addresses patient safety, clinical governance and resource management through a series of MobileTask Management, Handover and Observations applications.

Its solutions are platform independent and integrate into a hospital's existing IT and PAS systems.

Its handset independent applications function with multiple mobile devices.

A comparable example of the use of Nervecentre for the management of Out-of-Hours working is referenced in the QIPP collection on NICE Evidence. This shows how NHS staff are saving money without compromising on quality. QIPP reference 12/0017 published by Nottingham University Hospitals NHS Trust.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...